Heparin sodium 1,000 I.U./ml Solution for injection or concentrate for solution for infusion, 10ml ampoules Ireland - English - HPRA (Health Products Regulatory Authority)

heparin sodium 1,000 i.u./ml solution for injection or concentrate for solution for infusion, 10ml ampoules

pinewood laboratories ltd - heparin sodium - solution for injection/infusion - 1000 international unit(s)/millilitre - heparin group; heparin

Heparin sodium 1,000 I.U./ml Solution for injection or concentrate for solution for infusion, 5ml ampoules Ireland - English - HPRA (Health Products Regulatory Authority)

heparin sodium 1,000 i.u./ml solution for injection or concentrate for solution for infusion, 5ml ampoules

pinewood laboratories ltd - heparin sodium - solution for injection/infusion - 1000 international unit(s)/millilitre - heparin group; heparin

Heparin sodium 1,000 I.U./ml Solution for injection or concentrate for solution for infusion, 5ml vials Ireland - English - HPRA (Health Products Regulatory Authority)

heparin sodium 1,000 i.u./ml solution for injection or concentrate for solution for infusion, 5ml vials

pinewood laboratories ltd - heparin sodium - solution for injection/infusion - 1000 international unit(s)/millilitre - heparin group; heparin

Heparin sodium 25,000 I.U./ml Solution for injection or concentrate for solution for infusion, 0.2ml ampoules Ireland - English - HPRA (Health Products Regulatory Authority)

heparin sodium 25,000 i.u./ml solution for injection or concentrate for solution for infusion, 0.2ml ampoules

pinewood laboratories ltd, - heparin sodium - solution for injection/infusion - 25,000 international unit(s)/millilitre - heparin group; heparin

Heparin sodium 25,000 I.U./ml Solution for injection or concentrate for solution for infusion, 5 ml vials Ireland - English - HPRA (Health Products Regulatory Authority)

heparin sodium 25,000 i.u./ml solution for injection or concentrate for solution for infusion, 5 ml vials

pinewood laboratories ltd, - heparin sodium - solution injection or concentrate for solution infusion - 25000 international unit(s)/millilitre - heparin group; heparin

Heparin sodium 5,000 I.U./ml Solution for injection or concentrate for solution for infusion, 5 ml vials Ireland - English - HPRA (Health Products Regulatory Authority)

heparin sodium 5,000 i.u./ml solution for injection or concentrate for solution for infusion, 5 ml vials

pinewood laboratories ltd - heparin sodium - solution for injection/infusion - 5000 international unit(s)/millilitre - heparin group; heparin

Heparin sodium 25,000units/1ml solution for injection ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

heparin sodium 25,000units/1ml solution for injection ampoules

wockhardt uk ltd - heparin sodium - solution for injection - 25000unit/1ml

HEPARIN SODIUM injection, solution United States - English - NLM (National Library of Medicine)

heparin sodium injection, solution

mckesson packaging services business unit of mckesson corporation - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 1000 [usp'u] in 1 ml - heparin sodium injection, usp is indicated for: anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease (see dosage and administration ); prophylaxis and treatment of pulmonary embolism; atrial fibrillation with embolization; treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism. heparin may also be employed as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures. heparin sodium should not be used in patients with the following conditions: severe thrombocytopenia; when suitable blood coagulation tests, e.g., the whole

HEPARIN SODIUM- heparin sodium injection, solution United States - English - NLM (National Library of Medicine)

heparin sodium- heparin sodium injection, solution

safecor health, llc - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 5000 [usp'u] in 1 ml - heparin sodium injection, usp is indicated for: anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease (see dosage and administration ); prophylaxis and treatment of pulmonary embolism; atrial fibrillation with embolization; treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism. heparin may also be employed as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures. heparin sodium should not be used in patients with the following conditions: severe thrombocytopenia; when suitable blood coagulation tests, e.g., the whole b

HEPARIN SODIUM injection, solution United States - English - NLM (National Library of Medicine)

heparin sodium injection, solution

general injectables & vaccines, inc - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 5000 [usp'u] in 1 ml - heparin sodium injection is indicated for: anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease (see dosage and administration ); prophylaxis and treatment of pulmonary embolism; atrial fibrillation with embolization; diagnosis and treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism. heparin may also be employed as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures and in blood samples for laboratory purposes. heparin sodium should not be used in patients with the following conditions: severe thrombocytopenia; when suitable blood coagulation test